As of the date of disclosure of this announcement, the relevant parties are actively advancing various tasks related to the Transaction. Tinavi Medical Technologies Co., Ltd. expects that the Company's shares will be unable to resume trading from the opening of trading on July 23, 2026. In accordance with relevant regulations, the Company has applied to the Shanghai Stock Exchange for continued suspension of trading, and the Company's shares will remain suspended from trading from the opening of trading on July 23, 2026. The suspension period is expected not to exceed five trading days.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment